世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

毒性薬物検査市場(検査タイプ:検査タイプ:インビトロ、インビボ、インシリコ;検査方法:質量分析イメージング、電子顕微鏡、蛍光標識、免疫組織化学、その他) - 世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年


Toxicology Drug Testing Market (Testing Type: In Vitro, In Vivo, In Silico; Testing Method: Mass Spectrometry Imaging, Electron Microscopy, Fluorescence Labeling, Immunohistochemistry, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

毒物検査市場 - レポートの範囲 TMRの調査レポート「毒性薬物検査の世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会につ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2023年8月18日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
150 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

毒物検査市場 - レポートの範囲
TMRの調査レポート「毒性薬物検査の世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの毒性薬物検査の世界市場の収益を提供しています。また、2023年から2031年までの毒性薬物検査の世界市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、毒性薬物検査市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照した。

二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、世界の毒性薬物検査市場の様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用した。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、世界の毒物検査市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の毒物検査市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートは、世界の毒物検査市場の競争状況について掘り下げています。世界の毒性薬物検査市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、このレポートでプロファイリングされた世界の毒物検査市場のプレーヤーの属性です。

毒性薬物検査の世界市場レポートで回答された主な質問
- 予測期間中の全地域における毒物検査が生み出す売上高/収益は?
- 世界の毒物検査市場におけるビジネスチャンスは?
- 市場の主な促進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大する地域市場はどこか?
- 2031年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは?
- 世界市場で事業を展開する各企業の市場ポジションは?

毒性薬物検査市場 - 調査目的と調査アプローチ
毒性薬物検査の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと販売業者、製品承認のための規制シナリオについて詳細に説明しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。

本レポートでは、世界の毒性薬物検査市場を製品、エンドユーザー、地域の観点から分析している。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界の毒性薬物検査市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Toxicology Drug Testing Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Toxicology Drug Testing Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Regulatory Scenario by Region/Globally
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Testing Type, 2017-2031
        6.3.1. In Vitro
        6.3.2. In Vivo
        6.3.3. In Silico
    6.4. Market Attractiveness Analysis, by Testing Type
7. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Method
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Testing Method, 2017-2031
        7.3.1. Mass Spectrometry Imaging
        7.3.2. Electron Microscopy
        7.3.3. Fluorescence Labeling
        7.3.4. Immunohistochemistry
        7.3.5. Others
    7.4. Market Attractiveness Analysis, by Testing Method
8. Global Toxicology Drug Testing Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017-2031
        8.3.1. Drug Development
        8.3.2. Substance Abuse and Addiction
        8.3.3. Therapeutic Drug Monitoring
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Application
9. Global Toxicology Drug Testing Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Cosmetics Industry
        9.3.2. Healthcare Industry
            9.3.2.1. Hospital and Clinics
            9.3.2.2. Diagnostic Laboratories
            9.3.2.3. Pharmaceutical & Biotechnology Companies
            9.3.2.4. Others
        9.3.3. Food Industry
        9.3.4. Chemicals Industry
    9.4. Market Attractiveness Analysis, by End-user
10. Global Toxicology Drug Testing Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017-2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America Toxicology Drug Testing Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Testing Type, 2017-2031
        11.2.1. In Vitro
        11.2.2. In Vivo
        11.2.3. In Silico
    11.3. Market Value Forecast, by Testing Method, 2017-2031
        11.3.1. Mass Spectrometry Imaging
        11.3.2. Electron Microscopy
        11.3.3. Fluorescence Labeling
        11.3.4. Immunohistochemistry
        11.3.5. Others
    11.4. Market Value Forecast, by Application, 2017-2031
        11.4.1. Drug Development
        11.4.2. Substance Abuse and Addiction
        11.4.3. Therapeutic Drug Monitoring
        11.4.4. Others
    11.5. Market Value Forecast, by End-user, 2017-2031
        11.5.1. Cosmetics Industry
        11.5.2. Healthcare Industry
            11.5.2.1. Hospital and Clinics
            11.5.2.2. Diagnostic Laboratories
            11.5.2.3. Pharmaceutical & Biotechnology Companies
            11.5.2.4. Others
        11.5.3. Food Industry
        11.5.4. Chemicals Industry
    11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Testing Type
        11.7.2. By Testing Method
        11.7.3. By Application
        11.7.4. By End-user
        11.7.5. By Country/Sub-region
12. Europe Toxicology Drug Testing Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Testing Type, 2017-2031
        12.2.1. In Vitro
        12.2.2. In Vivo
        12.2.3. In Silico
    12.3. Market Value Forecast, by Testing Method, 2017-2031
        12.3.1. Mass Spectrometry Imaging
        12.3.2. Electron Microscopy
        12.3.3. Fluorescence Labeling
        12.3.4. Immunohistochemistry
        12.3.5. Others
    12.4. Market Value Forecast, by Application, 2017-2031
        12.4.1. Drug Development
        12.4.2. Substance Abuse and Addiction
        12.4.3. Therapeutic Drug Monitoring
        12.4.4. Others
    12.5. Market Value Forecast, by End-user, 2017-2031
        12.5.1. Cosmetics Industry
        12.5.2. Healthcare Industry
            12.5.2.1. Hospital and Clinics
            12.5.2.2. Diagnostic Laboratories
            12.5.2.3. Pharmaceutical & Biotechnology Companies
            12.5.2.4. Others
        12.5.3. Food Industry
        12.5.4. Chemicals Industry
    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Testing Type
        12.7.2. By Testing Method
        12.7.3. By Application
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Toxicology Drug Testing Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Testing Type, 2017-2031
        13.2.1. In Vitro
        13.2.2. In Vivo
        13.2.3. In Silico
    13.3. Market Value Forecast, by Testing Method, 2017-2031
        13.3.1. Mass Spectrometry Imaging
        13.3.2. Electron Microscopy
        13.3.3. Fluorescence Labeling
        13.3.4. Immunohistochemistry
        13.3.5. Others
    13.4. Market Value Forecast, by Application, 2017-2031
        13.4.1. Drug Development
        13.4.2. Substance Abuse and Addiction
        13.4.3. Therapeutic Drug Monitoring
        13.4.4. Others
    13.5. Market Value Forecast, by End-user, 2017-2031
        13.5.1. Cosmetics Industry
        13.5.2. Healthcare Industry
            13.5.2.1. Hospital and Clinics
            13.5.2.2. Diagnostic Laboratories
            13.5.2.3. Pharmaceutical & Biotechnology Companies
            13.5.2.4. Others
        13.5.3. Food Industry
        13.5.4. Chemicals Industry
    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Testing Type
        13.7.2. By Testing Method
        13.7.3. By Application
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Toxicology Drug Testing Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Testing Type, 2017-2031
        14.2.1. In Vitro
        14.2.2. In Vivo
        14.2.3. In Silico
    14.3. Market Value Forecast, by Testing Method, 2017-2031
        14.3.1. Mass Spectrometry Imaging
        14.3.2. Electron Microscopy
        14.3.3. Fluorescence Labeling
        14.3.4. Immunohistochemistry
        14.3.5. Others
    14.4. Market Value Forecast, by Application, 2017-2031
        14.4.1. Drug Development
        14.4.2. Substance Abuse and Addiction
        14.4.3. Therapeutic Drug Monitoring
        14.4.4. Others
    14.5. Market Value Forecast, by End-user, 2017-2031
        14.5.1. Cosmetics Industry
        14.5.2. Healthcare Industry
            14.5.2.1. Hospital and Clinics
            14.5.2.2. Diagnostic Laboratories
            14.5.2.3. Pharmaceutical & Biotechnology Companies
            14.5.2.4. Others
        14.5.3. Food Industry
        14.5.4. Chemicals Industry
    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Testing Type
        14.7.2. By Testing Method
        14.7.3. By Application
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Toxicology Drug Testing Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Testing Type, 2017-2031
        15.2.1. In Vitro
        15.2.2. In Vivo
        15.2.3. In Silico
    15.3. Market Value Forecast, by Testing Method, 2017-2031
        15.3.1. Mass Spectrometry Imaging
        15.3.2. Electron Microscopy
        15.3.3. Fluorescence Labeling
        15.3.4. Immunohistochemistry
        15.3.5. Others
    15.4. Market Value Forecast, by End-user, 2017-2031
        15.4.1. Drug Development
        15.4.2. Substance Abuse and Addiction
        15.4.3. Therapeutic Drug Monitoring
        15.4.4. Others
    15.5. Market Value Forecast, by Application, 2017-2031
        15.5.1. Cosmetics Industry
        15.5.2. Healthcare Industry
            15.5.2.1. Hospital and Clinics
            15.5.2.2. Diagnostic Laboratories
            15.5.2.3. Pharmaceutical & Biotechnology Companies
            15.5.2.4. Others
        15.5.3. Food Industry
        15.5.4. Chemicals Industry
    15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Testing Type
        15.7.2. By Testing Method
        15.7.3. By Application
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. TDAL Labs
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Thermo Fisher Scientific Inc.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Abbott
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Icahn School of Medicine at Mount Sinai
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Clinisys, Inc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Laboratory Corporation of America Holdings
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. SLUCARE
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Keystone Lab
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Shimadzu Scientific Instruments
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Other Players
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview

 

ページTOPに戻る


 

Summary

Toxicology Drug Testing Market – Scope of Report
TMR’s report on the global toxicology drug testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global toxicology drug testing market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global toxicology drug testing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the toxicology drug testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global toxicology drug testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global toxicology drug testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global toxicology drug testing market.

The report delves into the competitive landscape of the global toxicology drug testing market. Key players operating in the global toxicology drug testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global toxicology drug testing market profiled in this report.

Key Questions Answered in Global Toxicology Drug Testing Market Report
• What is the sales/revenue generated by toxicology drug testing across all regions during the forecast period?
• What are the opportunities in the global toxicology drug testing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Toxicology Drug Testing Market – Research Objectives and Research Approach
The comprehensive report on the global toxicology drug testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global toxicology drug testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global toxicology drug testing market.



ページTOPに戻る


Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Toxicology Drug Testing Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Toxicology Drug Testing Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Regulatory Scenario by Region/Globally
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Testing Type, 2017-2031
        6.3.1. In Vitro
        6.3.2. In Vivo
        6.3.3. In Silico
    6.4. Market Attractiveness Analysis, by Testing Type
7. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Method
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Testing Method, 2017-2031
        7.3.1. Mass Spectrometry Imaging
        7.3.2. Electron Microscopy
        7.3.3. Fluorescence Labeling
        7.3.4. Immunohistochemistry
        7.3.5. Others
    7.4. Market Attractiveness Analysis, by Testing Method
8. Global Toxicology Drug Testing Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017-2031
        8.3.1. Drug Development
        8.3.2. Substance Abuse and Addiction
        8.3.3. Therapeutic Drug Monitoring
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Application
9. Global Toxicology Drug Testing Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Cosmetics Industry
        9.3.2. Healthcare Industry
            9.3.2.1. Hospital and Clinics
            9.3.2.2. Diagnostic Laboratories
            9.3.2.3. Pharmaceutical & Biotechnology Companies
            9.3.2.4. Others
        9.3.3. Food Industry
        9.3.4. Chemicals Industry
    9.4. Market Attractiveness Analysis, by End-user
10. Global Toxicology Drug Testing Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017-2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America Toxicology Drug Testing Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Testing Type, 2017-2031
        11.2.1. In Vitro
        11.2.2. In Vivo
        11.2.3. In Silico
    11.3. Market Value Forecast, by Testing Method, 2017-2031
        11.3.1. Mass Spectrometry Imaging
        11.3.2. Electron Microscopy
        11.3.3. Fluorescence Labeling
        11.3.4. Immunohistochemistry
        11.3.5. Others
    11.4. Market Value Forecast, by Application, 2017-2031
        11.4.1. Drug Development
        11.4.2. Substance Abuse and Addiction
        11.4.3. Therapeutic Drug Monitoring
        11.4.4. Others
    11.5. Market Value Forecast, by End-user, 2017-2031
        11.5.1. Cosmetics Industry
        11.5.2. Healthcare Industry
            11.5.2.1. Hospital and Clinics
            11.5.2.2. Diagnostic Laboratories
            11.5.2.3. Pharmaceutical & Biotechnology Companies
            11.5.2.4. Others
        11.5.3. Food Industry
        11.5.4. Chemicals Industry
    11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Testing Type
        11.7.2. By Testing Method
        11.7.3. By Application
        11.7.4. By End-user
        11.7.5. By Country/Sub-region
12. Europe Toxicology Drug Testing Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Testing Type, 2017-2031
        12.2.1. In Vitro
        12.2.2. In Vivo
        12.2.3. In Silico
    12.3. Market Value Forecast, by Testing Method, 2017-2031
        12.3.1. Mass Spectrometry Imaging
        12.3.2. Electron Microscopy
        12.3.3. Fluorescence Labeling
        12.3.4. Immunohistochemistry
        12.3.5. Others
    12.4. Market Value Forecast, by Application, 2017-2031
        12.4.1. Drug Development
        12.4.2. Substance Abuse and Addiction
        12.4.3. Therapeutic Drug Monitoring
        12.4.4. Others
    12.5. Market Value Forecast, by End-user, 2017-2031
        12.5.1. Cosmetics Industry
        12.5.2. Healthcare Industry
            12.5.2.1. Hospital and Clinics
            12.5.2.2. Diagnostic Laboratories
            12.5.2.3. Pharmaceutical & Biotechnology Companies
            12.5.2.4. Others
        12.5.3. Food Industry
        12.5.4. Chemicals Industry
    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Testing Type
        12.7.2. By Testing Method
        12.7.3. By Application
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Toxicology Drug Testing Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Testing Type, 2017-2031
        13.2.1. In Vitro
        13.2.2. In Vivo
        13.2.3. In Silico
    13.3. Market Value Forecast, by Testing Method, 2017-2031
        13.3.1. Mass Spectrometry Imaging
        13.3.2. Electron Microscopy
        13.3.3. Fluorescence Labeling
        13.3.4. Immunohistochemistry
        13.3.5. Others
    13.4. Market Value Forecast, by Application, 2017-2031
        13.4.1. Drug Development
        13.4.2. Substance Abuse and Addiction
        13.4.3. Therapeutic Drug Monitoring
        13.4.4. Others
    13.5. Market Value Forecast, by End-user, 2017-2031
        13.5.1. Cosmetics Industry
        13.5.2. Healthcare Industry
            13.5.2.1. Hospital and Clinics
            13.5.2.2. Diagnostic Laboratories
            13.5.2.3. Pharmaceutical & Biotechnology Companies
            13.5.2.4. Others
        13.5.3. Food Industry
        13.5.4. Chemicals Industry
    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Testing Type
        13.7.2. By Testing Method
        13.7.3. By Application
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Toxicology Drug Testing Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Testing Type, 2017-2031
        14.2.1. In Vitro
        14.2.2. In Vivo
        14.2.3. In Silico
    14.3. Market Value Forecast, by Testing Method, 2017-2031
        14.3.1. Mass Spectrometry Imaging
        14.3.2. Electron Microscopy
        14.3.3. Fluorescence Labeling
        14.3.4. Immunohistochemistry
        14.3.5. Others
    14.4. Market Value Forecast, by Application, 2017-2031
        14.4.1. Drug Development
        14.4.2. Substance Abuse and Addiction
        14.4.3. Therapeutic Drug Monitoring
        14.4.4. Others
    14.5. Market Value Forecast, by End-user, 2017-2031
        14.5.1. Cosmetics Industry
        14.5.2. Healthcare Industry
            14.5.2.1. Hospital and Clinics
            14.5.2.2. Diagnostic Laboratories
            14.5.2.3. Pharmaceutical & Biotechnology Companies
            14.5.2.4. Others
        14.5.3. Food Industry
        14.5.4. Chemicals Industry
    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Testing Type
        14.7.2. By Testing Method
        14.7.3. By Application
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Toxicology Drug Testing Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Testing Type, 2017-2031
        15.2.1. In Vitro
        15.2.2. In Vivo
        15.2.3. In Silico
    15.3. Market Value Forecast, by Testing Method, 2017-2031
        15.3.1. Mass Spectrometry Imaging
        15.3.2. Electron Microscopy
        15.3.3. Fluorescence Labeling
        15.3.4. Immunohistochemistry
        15.3.5. Others
    15.4. Market Value Forecast, by End-user, 2017-2031
        15.4.1. Drug Development
        15.4.2. Substance Abuse and Addiction
        15.4.3. Therapeutic Drug Monitoring
        15.4.4. Others
    15.5. Market Value Forecast, by Application, 2017-2031
        15.5.1. Cosmetics Industry
        15.5.2. Healthcare Industry
            15.5.2.1. Hospital and Clinics
            15.5.2.2. Diagnostic Laboratories
            15.5.2.3. Pharmaceutical & Biotechnology Companies
            15.5.2.4. Others
        15.5.3. Food Industry
        15.5.4. Chemicals Industry
    15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Testing Type
        15.7.2. By Testing Method
        15.7.3. By Application
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. TDAL Labs
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Thermo Fisher Scientific Inc.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Abbott
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Icahn School of Medicine at Mount Sinai
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Clinisys, Inc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Laboratory Corporation of America Holdings
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. SLUCARE
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Keystone Lab
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Shimadzu Scientific Instruments
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Other Players
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Transparency Market Research社の医療分野での最新刊レポート

本レポートと同じKEY WORD(drug)の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/25 10:26

155.25 円

163.23 円

198.36 円

ページTOPに戻る